Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
02/2005
02/09/2005CN1188392C Process for synthesis of hydrocarbonfluoride
02/09/2005CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF
02/09/2005CN1188121C Therapeutic substituted guanidines
02/08/2005US6852878 Treating inflammatory disorders, cardiovascular diseases, occular diseases, autoimmune diseases, neurological disorders, and cancer. The compounds also can be used to treat hyperlipidemia and/or hypercholesterolemia.
02/08/2005US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular
02/08/2005US6852751 Difluorobutyric acid metalloprotease inhibitors
02/08/2005US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors
02/08/2005CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
02/08/2005CA2096525C Retroviral protease inhibitors
02/08/2005CA2096409C Retroviral protease inhibitors
02/08/2005CA2096408C Retroviral protease inhibitors
02/03/2005WO2005009941A1 Indane derivates as muscarinic receptor agonists
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005WO2005009928A2 Preparation and use of alkylating agents
02/03/2005WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
02/03/2005US20050027016 Polyamine compounds and compositions for use in conjection with cancer therapy
02/03/2005US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
02/03/2005US20050026907 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
02/03/2005US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke
02/03/2005CA2538520A1 Preparation and use of alkylating agents
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/03/2005CA2529036A1 Indane derivates as muscarinic receptor agonists
02/02/2005EP1501840A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and polymers therefrom
02/02/2005EP1501811A1 Process for preparing thiazole derivative and the intermediate compounds for preparing the same
02/02/2005EP1501789A1 Amidinylphenyl compounds and their use as fungicides
02/02/2005CN1575279A Substituted thioacetamides
02/02/2005CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
02/02/2005CN1572754A Method for producing organic compound by substituting halogen atoms
02/01/2005US6849763 Reacting 4-fluorothiophenol in methanol, adding methyl-1,2-epoxy-2-methylpropionate and ethyl acetate, recovering 2-hydroxy-2-methyl-3-(4-fluorophenylthio)propionic acid, then solidifying
02/01/2005US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides
02/01/2005US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
02/01/2005US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
02/01/2005CA2362698C Resorcinol derivatives
01/2005
01/27/2005WO2005007621A2 Ubiquitin ligase inhibitors
01/27/2005WO2005007104A2 Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease
01/27/2005WO2005007091A2 Histone deacetylase inhibitors and methods of use thereof
01/27/2005WO2005007076A2 Colchicine derivatives
01/27/2005WO2004075827A3 Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
01/27/2005US20050020831 Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents
01/27/2005US20050020680 Hydroxyfattysulfonic acid analogs
01/27/2005US20050020651 Butyric acid derivatives
01/27/2005US20050020518 under physiological conditions, containing a labile disulfide bond and a transduction signal such as transcriptional factor from Drosophila, ANTP; for the delivery of a compound to a cell; disulfide bond cleaved more rapidly than oxidized glutathione
01/27/2005US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
01/27/2005CA2800212A1 Histone deacetylase inhibitors and methods of use thereof
01/27/2005CA2521990A1 Colchicine derivatives
01/26/2005EP1499587A1 Process for synthesizing pharmaceutically active disulfide salts
01/26/2005EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1571766A Novel compounds, their preparation and use
01/26/2005CN1186332C New thryoid receptor ligands and process II
01/26/2005CN1186331C Substituted 2, 4-diamino-1, 3, 5-triazines as herbicides
01/26/2005CN1186320C Thiol and sulfur-containing O-(meth)acrylate counpounds and use thereof
01/26/2005CN1186319C Process for producing 4-bromothioanisole
01/26/2005CN1186315C O-anisamide derivatives
01/25/2005US6846958 Synthesis of benzimidate from benzoic acid
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/25/2005US6846843 β-thioamino acids
01/25/2005US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
01/20/2005WO2005005377A1 (2r, 5r)-6n-(1-iminoethyl)-2,6-diamino-5-methyl-4-thiohexanoic acid; salts thereof; a process for their preparation; pharmaceutical compositions containing them and their use in medecine
01/20/2005WO2005005376A2 Fungicidal phenoxyphenylhydrazine derivatives
01/20/2005WO2005005369A1 Preparation of 1,3-diphenylprop-2-en-1-one derivatives
01/20/2005WO2005004810A2 Arylsulfonamide derivatives
01/20/2005US20050014941 Cyanoalkylamino derivatives as protease inhibitors
01/20/2005US20050014840 Thiol sulfonamide metalloprotease inhibitors
01/20/2005US20050014839 Histone deacetylase inhibitors and methods of use thereof
01/20/2005US20050014724 Immunosuppressant compounds and compositions
01/20/2005US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines
01/20/2005US20050014095 Sulfonate and a resist composition
01/20/2005US20050012092 (4,5,9,10-Tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester, method of synthesizing thereof, and molecular electronic device using the same
01/20/2005US20050012072 Liquid crystals; dielectric anisotropy
01/20/2005CA2535986A1 Fungicidal phenoxyphenylhydrazine derivatives
01/20/2005CA2525091A1 Water-soluble shps as novel alkylating agents
01/19/2005EP1498467A1 Alkyl and aryl trifluoromethoxytetrafluorosulfuranes
01/19/2005EP1497300A2 Plasma carboxypeptidase b inhibitors
01/19/2005EP1497268A2 Nitric oxide donors, compositions and methods of use
01/19/2005EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
01/19/2005EP1497251A1 3-keto or 3-oximoether substituted benzoylcyclohexanediones
01/19/2005EP1496838A2 Substituted amides
01/19/2005CN1568298A Luminous compounds and labeling reagents using the same
01/19/2005CN1566087A Amino acid iron chelate, preparation and application thereof
01/19/2005CN1566086A Amino acid calcium chelate, preparation and application thereof
01/19/2005CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof
01/19/2005CN1185223C Novel Compounds and methods for synthesis and therapy
01/19/2005CN1184897C Fluidizable and methionine containing shaped body and method for preparing same
01/13/2005WO2005003094A1 Diarylmethyl derivatives as potassium channel modulators
01/13/2005WO2004099129A3 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
01/13/2005WO2003078390A8 Phenolic compound and recording material containing the same
01/13/2005US20050009924 1,4-, 1,5- and 1,8-difunctionalized anthraquinones, useful for treating abnormal proliferation including cancer, for enhancing an anti-oxidation effect, human telomerase activity, and tissue engineering application, and for stem cell research
01/13/2005US20050009871 Ubiquitin ligase inhibitors
01/13/2005US20050009816 Potassium channel modulators
01/13/2005US20050009786 Immunosuppressant compounds and compositions
01/12/2005EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
01/12/2005EP1494989A2 Compounds that modulate ppar activity and methods for their preparation
01/12/2005EP1019424B1 Reagent and method for attaching target molecules to a surface
01/12/2005CN1564812A Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates
01/12/2005CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
01/12/2005CN1184199C Method for preparing methylthioamino acid or alkali salts thereof
01/11/2005US6841502 For catalytic polymerization of ethylene/olefin copolymers
01/11/2005US6841499 Homogeneous rhodium complexes bearing phosphines
01/06/2005WO2005000834A1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 272